# A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831

> **NCT00668070** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 114 (actual)

## Conditions studied

- Non-Alcoholic Steatohepatitis

## Interventions

- **DRUG:** ASP9831
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00668070
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2013-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668070, "A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00668070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*